UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 285

Sortiert nach

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

Journal of Nuclear Medicine, 2016-08, Vol.57 (8), p.1316-1322

2016

Volltextzugriff (PDF)

[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease

European journal of nuclear medicine and molecular imaging, 2019-09, Vol.46 (10), p.2077-2089

2019

Volltextzugriff (PDF)

α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?

Journal of Nuclear Medicine, 2024-02, Vol.65 (2), p.174-175

Seibyl, John P

2024

Volltextzugriff (PDF)

α-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?

Journal of Nuclear Medicine, 2022-10, Vol.63 (10), p.1463-1466

Seibyl, John P.

2022

Volltextzugriff (PDF)

Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders

Journal of Nuclear Medicine, 2023-01, Vol.64 (1), p.12-19

Seibyl, John P

2023

Volltextzugriff (PDF)

Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging

Neurology, 2016-02, Vol.86 (8), p.748

2016

Volltextzugriff (PDF)

Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study

International journal of molecular sciences, 2021-03, Vol.22 (6), p.2863

2021

Volltextzugriff (PDF)

The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease

JAMA neurology, 2014-12, Vol.71 (12), p.1520

2014

Volltextzugriff (PDF)

Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study

Brain sciences, 2022-02, Vol.12 (3), p.314

2022

Volltextzugriff (PDF)

Early detection of amyloid load using 18F-florbetaben PET

Alzheimer's research & therapy, 2021-03, Vol.13 (1), p.1-67, Article 67

2021

Volltextzugriff (PDF)

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

The American journal of psychiatry, 2000-10, Vol.157 (10), p.1700-1703

2000

Volltextzugriff (PDF)

Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome

Brain sciences, 2020-11, Vol.10 (12), p.899

2020

Volltextzugriff (PDF)

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

Journal of Nuclear Medicine, 2012-03, Vol.53 (3), p.378-384

2012

Volltextzugriff (PDF)

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

The American journal of psychiatry, 2000-07, Vol.157 (7), p.1108-1114

2000

Volltextzugriff (PDF)

Age-Related Decline in Dopamine Transporters: Analysis of Striatal Subregions, Nonlinear Effects, and Hemispheric Asymmetries

The American journal of geriatric psychiatry, 2002-01, Vol.10 (1), p.36-43

2002

Volltextzugriff (PDF)

Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: A β-CIT imaging study

Neurobiology of disease, 2010-05, Vol.38 (2), p.219-225

2010

Volltextzugriff (PDF)

A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18F-MK-6240 PET

The Journal of nuclear medicine (1978), 2023-03, Vol.64 (3), p.444-451

2023

Volltextzugriff (PDF)

Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18

Journal of Nuclear Medicine, 2018-06, Vol.59 (6), p.937-943

2018

Volltextzugriff (PDF)

Single-Photon Emission Computed Tomography and Positron Emission Tomography Evaluations of Patients With Central Motor Disorders

Seminars in nuclear medicine, 2008-07, Vol.38 (4), p.274-286

Seibyl, John P., MD

2008

Volltextzugriff (PDF)

A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18 F-MK-6240 PET

Journal of Nuclear Medicine, 2023-03, Vol.64 (3), p.444-451

2023

Volltextzugriff (PDF)

Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers

Molecular imaging and biology, 2019-06, Vol.21 (3), p.509-518

2019

Volltextzugriff (PDF)

Decreased Beta2-nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates

Synapse (New York, N.Y.), 2010-09, Vol.64 (9), p.729-732

2010

Volltextzugriff (PDF)

Changes in the Cholinergic System between Bipolar Depression and Euthymia as Measured with [123 I]5IA Single Photon Emission Computed Tomography

Biological psychiatry (1969), 2013-11, Vol.74 (10), p.768-776

2013

Volltextzugriff (PDF)

3,4-Dihydroxy-6-[18 F]-Fluoro-L-Phenylalanine Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors

Seminars in nuclear medicine, 2007-11, Vol.37 (6), p.440-450

2007

Volltextzugriff (PDF)

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(268)

Publikationsform

Artikel
(284)
Reviews
(1)

Sprache

Englisch
(285)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Humans
(138)
Life Sciences & Biomedicine
(127)
Science & Technology
(127)
Male
(118)
Female
(115)
Adult
(99)
Biological And Medical Sciences
(81)
Medical Sciences
(76)
Middle Aged
(66)
Tomography, Emission-Computed, Single-Photon
(66)
Brain - Diagnostic Imaging
(59)
Neurosciences & Neurology
(53)
Brain - Metabolism
(52)
Psychiatry
(46)
Radiology, Nuclear Medicine & Medical Imaging
(43)
Iodine Radioisotopes
(41)
Spect
(41)
Aged
(35)
Neurology
(34)
Neurosciences
(33)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

[18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer’s disease

α-Synuclein Seeding Amplification Assay: A Breakthrough in Diagnosing Parkinson Disease?

α-Synuclein PET and Parkinson Disease Therapeutic Trials: Ever the Twain Shall Meet?

Imaging Biomarkers for Central Nervous System Drug Development and Future Clinical Utility: Lessons from Neurodegenerative Disorders

Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging

Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study

The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease

Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study

Early detection of amyloid load using 18F-florbetaben PET

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects

Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients

Age-Related Decline in Dopamine Transporters: Analysis of Striatal Subregions, Nonlinear Effects, and Hemispheric Asymmetries

Occupational exposure to PCBs reduces striatal dopamine transporter densities only in women: A β-CIT imaging study

A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18F-MK-6240 PET

Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18

18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy

Single-Photon Emission Computed Tomography and Positron Emission Tomography Evaluations of Patients With Central Motor Disorders

A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18 F-MK-6240 PET

Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers

Decreased Beta2-nicotinic acetylcholine receptor availability after chronic ethanol exposure in nonhuman primates

Changes in the Cholinergic System between Bipolar Depression and Euthymia as Measured with [123 I]5IA Single Photon Emission Computed Tomography

3,4-Dihydroxy-6-[18 F]-Fluoro-L-Phenylalanine Positron Emission Tomography in Patients With Central Motor Disorders and in Evaluation of Brain and Other Tumors

Suchergebnisse filtern